Nifty
:
24123.85
Sensex
:
80113.52
-18.10 (-0.08%)
672.07 (0.85%)
Nifty
Sensex
:
:
24123.85
80113.52
-18.10 (-0.08%)
672.07 (0.85%)

Granules India Ltd.

Pharmaceuticals & Drugs - API

Rating :
59/99

BSE: 532482 | NSE: GRANULES

NSE BSE
491.20
02-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  494.80
  •  501.50
  •  484.55
  •  494.65
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1444277
  •  7134.43
  •  507.35
  •  287.70

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 11,897.88
  • 29.36
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 12,734.72
  • 0.31%
  • 3.69

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 41.96%
  • 4.19%
  • 19.38%
  • FII
  • DII
  • Others
  • 19.57%
  • 10.68%
  • 4.22%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.20
  • 14.63
  • 11.70

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.16
  • 18.92
  • 1.32

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 21.25
  • 22.45
  • -2.03

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.91
  • 16.38
  • 16.93

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.95
  • 3.12
  • 3.08

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.66
  • 10.71
  • 10.78

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
1,175.78
1,195.50
-1.65%
1,155.58
1,146.13
0.82%
1,189.49
1,150.73
3.37%
985.52
1,019.56
-3.34%
Expenses
920.08
967.38
-4.89%
905.10
914.83
-1.06%
976.51
907.83
7.57%
848.69
808.05
5.03%
EBITDA
255.70
228.12
12.09%
250.48
231.29
8.30%
212.97
242.91
-12.33%
136.82
211.50
-35.31%
EBIDTM
21.75%
19.08%
21.68%
20.18%
17.90%
21.11%
13.88%
20.74%
Other Income
1.87
3.38
-44.67%
0.65
0.95
-31.58%
1.53
4.79
-68.06%
0.35
4.67
-92.51%
Interest
28.76
18.80
52.98%
28.65
16.97
68.83%
25.96
13.22
96.37%
22.46
6.94
223.63%
Depreciation
53.18
48.71
9.18%
52.39
48.36
8.33%
52.52
44.06
19.20%
49.24
43.36
13.56%
PBT
175.64
163.99
7.10%
170.09
166.90
1.91%
136.02
190.41
-28.56%
65.47
165.87
-60.53%
Tax
45.99
44.38
3.63%
44.44
42.57
4.39%
33.91
45.32
-25.18%
17.58
38.30
-54.10%
PAT
129.65
119.60
8.40%
125.65
124.33
1.06%
102.12
145.09
-29.62%
47.89
127.57
-62.46%
PATM
11.03%
10.00%
10.87%
10.85%
8.58%
12.61%
4.86%
12.51%
EPS
5.35
4.94
8.30%
5.18
5.14
0.78%
4.21
5.84
-27.91%
1.98
5.14
-61.48%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
4,506.37
4,511.92
3,764.92
3,237.54
2,598.65
2,279.20
1,684.62
1,410.57
1,357.18
1,292.92
1,095.86
Net Sales Growth
-0.12%
19.84%
16.29%
24.59%
14.02%
35.29%
19.43%
3.93%
4.97%
17.98%
 
Cost Of Goods Sold
2,021.25
2,307.28
1,883.64
1,391.28
1,280.93
1,255.56
896.32
679.63
725.03
746.95
645.25
Gross Profit
2,485.12
2,204.63
1,881.28
1,846.27
1,317.72
1,023.64
788.30
730.93
632.15
545.97
450.61
GP Margin
55.15%
48.86%
49.97%
57.03%
50.71%
44.91%
46.79%
51.82%
46.58%
42.23%
41.12%
Total Expenditure
3,650.38
3,598.60
3,043.30
2,382.31
2,073.33
1,895.16
1,406.20
1,111.73
1,081.29
1,084.31
937.57
Power & Fuel Cost
-
95.69
74.66
68.85
59.74
57.67
48.22
38.67
34.97
45.73
36.70
% Of Sales
-
2.12%
1.98%
2.13%
2.30%
2.53%
2.86%
2.74%
2.58%
3.54%
3.35%
Employee Cost
-
420.35
366.44
324.29
259.04
209.82
165.21
140.19
117.57
106.96
85.84
% Of Sales
-
9.32%
9.73%
10.02%
9.97%
9.21%
9.81%
9.94%
8.66%
8.27%
7.83%
Manufacturing Exp.
-
273.93
298.74
228.39
177.94
157.62
120.84
88.60
66.97
50.89
38.68
% Of Sales
-
6.07%
7.93%
7.05%
6.85%
6.92%
7.17%
6.28%
4.93%
3.94%
3.53%
General & Admin Exp.
-
187.96
134.41
172.28
125.63
99.96
83.05
67.65
60.38
59.84
44.42
% Of Sales
-
4.17%
3.57%
5.32%
4.83%
4.39%
4.93%
4.80%
4.45%
4.63%
4.05%
Selling & Distn. Exp.
-
280.00
247.45
159.80
112.17
91.84
83.08
81.37
67.75
71.70
85.04
% Of Sales
-
6.21%
6.57%
4.94%
4.32%
4.03%
4.93%
5.77%
4.99%
5.55%
7.76%
Miscellaneous Exp.
-
33.38
37.96
37.42
57.88
22.69
9.49
15.61
8.62
2.24
85.04
% Of Sales
-
0.74%
1.01%
1.16%
2.23%
1.00%
0.56%
1.11%
0.64%
0.17%
0.15%
EBITDA
855.97
913.32
721.62
855.23
525.32
384.04
278.42
298.84
275.89
208.61
158.29
EBITDA Margin
18.99%
20.24%
19.17%
26.42%
20.22%
16.85%
16.53%
21.19%
20.33%
16.13%
14.44%
Other Income
4.40
14.29
18.22
26.88
36.56
26.68
10.84
9.93
5.62
4.34
4.31
Interest
105.83
55.93
23.21
26.28
27.02
28.46
33.06
32.26
37.07
32.35
20.43
Depreciation
207.33
184.49
158.63
151.46
136.95
105.48
76.20
71.51
58.40
52.65
29.81
PBT
547.22
687.17
558.00
704.36
397.90
276.78
180.00
204.99
186.03
127.96
112.36
Tax
141.92
170.58
145.24
154.91
115.73
89.11
63.40
65.20
61.15
37.05
37.13
Tax Rate
25.93%
24.82%
26.03%
21.99%
27.19%
32.20%
35.22%
31.81%
32.87%
28.95%
33.05%
PAT
405.31
516.60
412.76
549.46
309.91
187.67
116.60
139.79
124.89
90.91
75.23
PAT before Minority Interest
405.31
516.60
412.76
549.46
309.91
187.67
116.60
139.79
124.89
90.91
75.23
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
8.99%
11.45%
10.96%
16.97%
11.93%
8.23%
6.92%
9.91%
9.20%
7.03%
6.86%
PAT Growth
-21.54%
25.16%
-24.88%
77.30%
65.14%
60.95%
-16.59%
11.93%
37.38%
20.84%
 
EPS
16.72
21.31
17.03
22.67
12.79
7.74
4.81
5.77
5.15
3.75
3.10

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
2,834.91
2,586.54
2,173.27
1,843.72
1,529.47
1,304.18
903.60
661.60
431.16
355.96
Share Capital
24.20
24.80
24.77
25.42
25.42
25.38
22.87
21.67
20.43
20.28
Total Reserves
2,792.68
2,545.01
2,126.23
1,800.02
1,493.09
1,273.38
878.28
611.13
410.74
335.43
Non-Current Liabilities
254.73
282.83
366.30
485.98
552.63
488.19
187.99
246.62
356.52
343.51
Secured Loans
148.64
233.70
333.81
414.83
478.78
433.13
123.90
183.66
302.59
295.86
Unsecured Loans
0.00
0.00
0.00
6.69
0.00
0.00
0.34
0.55
0.62
13.38
Long Term Provisions
29.26
28.31
24.84
21.50
12.58
7.70
7.25
5.58
4.03
3.97
Current Liabilities
1,813.50
1,641.60
1,173.10
893.40
896.48
877.91
787.13
654.75
415.03
292.54
Trade Payables
782.13
638.61
541.05
356.88
323.48
274.35
215.98
181.10
187.63
135.54
Other Current Liabilities
193.19
200.85
194.25
153.16
113.60
69.84
93.43
79.21
88.98
47.78
Short Term Borrowings
810.88
765.58
409.27
371.69
454.21
525.10
473.83
392.85
124.97
100.91
Short Term Provisions
27.31
36.56
28.53
11.66
5.20
8.62
3.90
1.58
13.45
8.30
Total Liabilities
4,903.14
4,511.53
3,712.67
3,223.10
2,978.58
2,670.28
1,878.72
1,562.97
1,202.71
992.01
Net Block
1,910.92
1,541.17
1,332.00
1,203.97
944.25
776.73
644.34
559.94
616.55
482.47
Gross Block
2,981.22
2,461.77
2,145.15
1,875.23
1,472.94
1,199.63
983.66
822.98
843.76
653.90
Accumulated Depreciation
1,070.30
920.59
813.15
671.26
528.69
422.90
339.32
263.05
227.21
171.43
Non Current Assets
2,328.99
2,006.54
1,715.68
1,594.41
1,696.34
1,483.71
1,050.55
744.97
699.69
611.55
Capital Work in Progress
239.39
356.23
239.08
294.20
495.95
514.52
267.43
76.56
62.03
124.56
Non Current Investment
21.21
19.67
18.99
19.34
210.42
156.56
108.23
70.11
0.19
0.19
Long Term Loans & Adv.
157.47
89.47
125.61
76.89
45.72
35.91
30.56
38.37
20.76
4.33
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.15
0.00
Current Assets
2,574.15
2,504.99
1,997.00
1,628.70
1,282.24
1,186.57
828.16
818.00
500.36
376.92
Current Investments
0.00
0.00
0.00
109.85
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
1,149.41
978.55
782.18
438.43
384.21
279.95
269.18
253.72
224.52
174.16
Sundry Debtors
948.54
924.95
765.42
662.04
673.54
628.25
417.70
375.35
136.91
110.91
Cash & Bank
312.79
409.46
271.04
283.94
89.04
115.64
49.80
130.29
65.31
41.75
Other Current Assets
163.41
61.67
50.74
42.60
135.45
162.73
91.49
58.65
73.63
50.10
Short Term Loans & Adv.
114.19
130.35
127.61
91.83
98.46
114.09
51.66
48.68
2.05
28.76
Net Current Assets
760.65
863.38
823.90
735.30
385.76
308.65
41.03
163.25
85.33
84.38
Total Assets
4,903.14
4,511.53
3,712.68
3,223.11
2,978.58
2,670.28
1,878.71
1,562.97
1,202.72
992.01

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
738.75
332.06
432.48
476.19
262.24
-0.65
188.24
151.43
150.28
107.95
PBT
687.17
558.00
704.36
425.64
276.78
180.00
204.99
186.03
127.96
112.36
Adjustment
237.69
176.29
194.43
156.88
149.85
107.45
95.14
92.63
85.37
50.39
Changes in Working Capital
-10.31
-257.19
-274.95
12.75
-75.94
-230.03
-52.37
-79.70
-31.34
-31.03
Cash after chg. in Working capital
914.55
477.11
623.84
595.27
350.69
57.42
247.77
198.97
182.00
131.73
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-175.80
-145.05
-191.37
-119.08
-88.45
-58.07
-59.53
-47.54
-31.72
-23.78
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-191.36
-380.12
-277.13
-160.63
-269.82
-462.31
-326.09
-161.65
-145.55
-254.63
Net Fixed Assets
-104.53
-302.61
-204.42
-124.57
-176.36
-282.01
-249.86
-75.62
-231.53
-64.60
Net Investments
-80.00
-5.00
-36.29
-48.78
-431.34
-0.01
13.84
-16.48
72.98
-94.69
Others
-6.83
-72.51
-36.42
12.72
337.88
-180.29
-90.07
-69.55
13.00
-95.34
Cash from Financing Activity
-440.29
190.00
-299.31
-212.85
-17.43
528.62
55.87
85.67
18.83
146.72
Net Cash Inflow / Outflow
107.10
141.94
-143.97
102.70
-25.01
65.66
-81.98
75.44
23.56
0.04
Opening Cash & Equivalents
184.71
41.84
185.93
83.02
108.03
42.37
124.35
54.85
41.75
41.71
Closing Cash & Equivalent
291.56
184.71
41.84
185.93
83.02
108.03
42.37
130.29
65.31
41.75

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
116.38
103.62
86.85
71.80
59.73
51.17
39.40
29.20
20.98
17.36
ROA
10.97%
10.04%
15.84%
9.99%
6.64%
5.13%
8.12%
9.03%
8.31%
8.98%
ROE
19.18%
17.49%
27.64%
18.54%
13.32%
10.60%
18.23%
23.53%
23.29%
24.20%
ROCE
19.63%
17.37%
25.42%
17.22%
12.71%
11.09%
16.57%
20.16%
18.75%
19.90%
Fixed Asset Turnover
1.66
1.63
1.97
1.75
1.78
1.55
1.59
1.66
1.77
2.14
Receivable days
75.78
81.94
65.94
83.34
100.03
112.83
100.84
67.60
33.47
29.73
Inventory Days
86.07
85.35
56.39
51.34
51.03
59.23
66.49
63.11
54.79
50.77
Payable days
112.38
114.29
117.79
58.20
54.96
62.37
64.87
59.99
53.57
43.67
Cash Conversion Cycle
49.48
52.99
4.54
76.48
96.10
109.70
102.46
70.72
34.69
36.83
Total Debt/Equity
0.38
0.43
0.39
0.49
0.65
0.75
0.73
1.01
1.14
1.25
Interest Cover
13.29
25.04
27.80
16.75
10.72
6.44
7.36
6.02
4.96
6.50

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014

News Update:


  • Granules India reports 8% rise in Q4 consolidated net profit
    15th May 2024, 15:16 PM

    Total consolidated income of the company decreased by 1.77% at Rs 1,177.65 crore for Q4FY24

    Read More
  • Granules India - Quarterly Results
    15th May 2024, 12:33 PM

    Read More
  • Granules India’s arm gets USFDA’s approval for Colchicine Capsules
    30th Apr 2024, 10:50 AM

    Granules now have a total of 64 ANDA approvals from the USFDA

    Read More
  • Granules India gets zero observations from USFDA for Unit V facility in Andhra Pradesh
    13th Apr 2024, 13:03 PM

    This facility manufactures APIs & formulations of oncology and non-oncology products

    Read More
  • Granules India’s arm gets VAI classification from USFDA for USA Facility
    3rd Apr 2024, 14:11 PM

    Earlier, the USFDA had issued Form 483 with 5 observations post inspection on December 16, 2023, which has been now classified as VAI

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.